Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Industry
Laboratory Analytical Instruments
Location
47215 Lakeview Boulevard, Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 654 % -11.6%
Quick Ratio 82 % -29.8%
Debt-to-equity 25.8 % +5%
Return On Equity -1.39 % -116%
Return On Assets -1.13 % -106%
Operating Margin -11.8 % +90.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128M shares -2.42%
Common Stock, Shares, Outstanding 129M shares -1.15%
Entity Public Float 670M USD -35%
Common Stock, Value, Issued 129K USD -1.53%
Weighted Average Number of Shares Outstanding, Basic 131M shares -3.45%
Weighted Average Number of Shares Outstanding, Diluted 131M shares -3.45%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 201M USD +813%
Revenue from Contract with Customer, Excluding Assessed Tax 200M USD +3.85%
Research and Development Expense 39.4M USD -10.8%
Selling and Marketing Expense 49.1M USD -0.07%
General and Administrative Expense 43.1M USD -1.95%
Operating Income (Loss) -20.5M USD +26.3%
Nonoperating Income (Expense) 14.8M USD +22.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -5.7M USD +63.7%
Income Tax Expense (Benefit) 320K USD
Net Income (Loss) Attributable to Parent -5.85M USD -125%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 98.7M USD -41%
Accounts Receivable, after Allowance for Credit Loss, Current 60.6M USD +8.33%
Inventory, Net 43.9M USD -27.9%
Other Assets, Current 1.94M USD -12.9%
Assets, Current 396M USD +1.12%
Property, Plant and Equipment, Net 18M USD -2.41%
Operating Lease, Right-of-Use Asset 10.2M USD -6.31%
Intangible Assets, Net (Excluding Goodwill) 20.1M USD -12.8%
Goodwill 16.7M USD +2.97%
Other Assets, Noncurrent 4.76M USD +40.6%
Assets 500M USD +1.02%
Accrued Liabilities, Current 21.4M USD +7.03%
Contract with Customer, Liability, Current 25.5M USD +12.3%
Liabilities, Current 67.7M USD +20.3%
Contract with Customer, Liability, Noncurrent 16.1M USD +6.38%
Operating Lease, Liability, Noncurrent 7.55M USD -20.3%
Other Liabilities, Noncurrent 2.36M USD -2.76%
Liabilities 104M USD +2.34%
Accumulated Other Comprehensive Income (Loss), Net of Tax 16K USD
Retained Earnings (Accumulated Deficit) -35.2M USD -20.6%
Stockholders' Equity Attributable to Parent 396M USD +0.68%
Liabilities and Equity 500M USD +1.02%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.96M USD +38.5%
Net Cash Provided by (Used in) Financing Activities 1.61M USD
Net Cash Provided by (Used in) Investing Activities -5.75M USD +96.6%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 129M shares -1.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.51M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 98.7M USD -41.1%
Deferred Tax Assets, Valuation Allowance 2.8M USD +23.5%
Deferred Tax Assets, Gross 38.8M USD +7.75%
Operating Lease, Liability 11.3M USD -5.16%
Depreciation 3.5M USD +25%
Payments to Acquire Property, Plant, and Equipment 567K USD +12.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.73M USD +62.8%
Lessee, Operating Lease, Liability, to be Paid 11.9M USD -6.37%
Property, Plant and Equipment, Gross 26.7M USD +9.67%
Operating Lease, Liability, Current 3.76M USD +53.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.89M USD +9.19%
Lessee, Operating Lease, Liability, to be Paid, Year One 4M USD +46.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +37%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 559K USD -25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.52M USD -3.08%
Deferred Tax Assets, Operating Loss Carryforwards 1.61M USD +13.9%
Unrecognized Tax Benefits 3.6M USD -0.99%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.06M USD -10.9%
Additional Paid in Capital 431M USD +1.75%
Amortization of Intangible Assets 3.7M USD +15.6%
Depreciation, Depletion and Amortization 1.7M USD +69.7%
Deferred Tax Assets, Net of Valuation Allowance 36M USD +6.69%
Share-based Payment Arrangement, Expense 26.8M USD +21.8%
Interest Expense 1.84M USD -30.8%